Skip to content
HowShorted

UroGen Pharma Ltd. short interest in 2026

In 2026, UroGen Pharma Ltd.'s disclosed short interest ran from 22.58% of shares outstanding on 15 Jan 2026 to 12.78% on 15 Sep 2026, a change of -9.80 percentage points. The year's high was 22.58% on 15 Jan 2026 and its low 9.39% on 31 Jul 2026, averaging 15.38% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.12 days on 13 Feb 2026. Full history: UroGen Pharma Ltd..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for UroGen Pharma Ltd. in 2026

2026 in figures

Start of year
22.58% (15 Jan 2026)
End of year
12.78% (15 Sep 2026)
Change
-9.80 pp
High
22.58% (15 Jan 2026)
Low
9.39% (31 Jul 2026)
Average
15.38%
Highest days to cover
15.12 (13 Feb 2026)
SEC filings marked
6

Every report in 2026

UroGen Pharma Ltd. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202622.58%14.52
30 Jan 202622.00%14.56
13 Feb 202619.94%15.12
27 Feb 202617.13%10.84
13 Mar 202618.44%7.8410-K filed, results (8-K)
31 Mar 202617.84%11.83
15 Apr 202616.72%11.19
30 Apr 202615.46%8.88
15 May 202613.88%5.8210-Q filed, results (8-K)
29 May 202614.21%11.09
15 Jun 202613.46%9.87
30 Jun 202612.76%9.42
15 Jul 202611.68%6.90
31 Jul 20269.39%6.64
14 Aug 202610.48%4.8010-Q filed, results (8-K)
31 Aug 202612.78%6.79
15 Sep 202612.78%9.16

See also: UroGen Pharma Ltd.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.